Hi there!
I am wondering if anyone can answer a question I have regarding the use of
clinically isolated human secretory IgA in an eliza. I want to know if the
secretory component of the antibody will inhibit binding of the secondary
antibody (peroxidase labeled goat IgG anti human IgA) and/or the development
of the eliza. Any other information regarding the use of s-IgA in
lab protocols that may cause it to react differently than "normal"
antibodies would be appreciated!
Thanks in advance for any help!
Lynne Whitehead
U of Maryland - Microbiology Dept.
